About Us

Stelexis Therapeutics is committed to transforming cancer treatment through the discovery of novel targets aimed at the tumor’s origin. Pre-cancer and cancer stem cells (cancerous stem cells) are a primary cause of cancer progression and relapse, and they’re typically not eliminated by current treatment approaches. Previously, identifying targets on cancerous stem cells was almost impossible due to difficulties isolating, propagating and maintaining clinically relevant stem cells for research. Aided by seminal discoveries at leading academic institutions, the Company has developed a proprietary platform, called TumorOrigin™, which enables unprecedented study of these cells for drug discovery.

Our Approach

The TumorOrigin™ platform is designed to discover novel, druggable targets on cancerous stem cells. Utilizing large banks of patient-derived samples, this proprietary approach isolates, expands and maintains these rare cells. The platform is also capable of overcoming former limitations, such as insufficient cell count and cell survival, which until now impeded this area of cancer research. The Company is advancing two lead candidates targeting cancerous stem cells into clinical development.

Our Programs

Stelexis discovery efforts have led to the identification of two candidates targeting the elimination of cancerous stem cells for AML and solid tumors: STLX1018 and STLX1022.

Leadership

Zoi Karoulia

Senior Scientist Drug Discovery

Read More

Jiahao Chen

Senior Scientist TumorOrigin™ Platform

Read More

Lynn Biderman

Senior Scientist Drug Discovery

Read More

Ilhem Guernah

Research Scientist & Lab Manager

Read More

Yasumi Nakayama

Senior Research Associate

Read More

Nicole Covino

Project Manager

Read More

Adriana Roopnariane

Research Scientist

Read More

Bozena Bugaj-Gaweda

Research Scientist

Read More

Lumie Benard

Research Associate

Read More

Haleigh Hoch

Research Associate

Read More

See More

Board of Directors

Bob Jackson

Read More

Mark Shtilerman

Read More

Peter Steelman

Read More

Uli Steidl

Read More

Derrick Rossi

Read More

Investors

 

Careers

Stelexis is building a team of experienced professionals that share a common goal: to improve the lives of patients with cancer. We seek to hire dynamic, motivated individuals who are committed to discovering and developing novel oncology therapeutic approaches, and we invite you to reach out for more information here: